rs201161155
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_080390.4(TCEAL2):c.14T>A(p.Phe5Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000115 in 1,203,862 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 44 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080390.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCEAL2 | ENST00000372780.6 | c.14T>A | p.Phe5Tyr | missense_variant | Exon 3 of 3 | 1 | NM_080390.4 | ENSP00000361866.1 | ||
TCEAL2 | ENST00000476749.1 | n.799T>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
TCEAL2 | ENST00000329035.2 | c.14T>A | p.Phe5Tyr | missense_variant | Exon 3 of 3 | 5 | ENSP00000332359.2 | |||
TCEAL2 | ENST00000651085.1 | n.153+399T>A | intron_variant | Intron 2 of 3 |
Frequencies
GnomAD3 genomes AF: 0.0000445 AC: 5AN: 112249Hom.: 0 Cov.: 24 AF XY: 0.0000581 AC XY: 2AN XY: 34447
GnomAD3 exomes AF: 0.0000398 AC: 7AN: 175852Hom.: 0 AF XY: 0.0000482 AC XY: 3AN XY: 62220
GnomAD4 exome AF: 0.000123 AC: 134AN: 1091558Hom.: 0 Cov.: 31 AF XY: 0.000117 AC XY: 42AN XY: 359426
GnomAD4 genome AF: 0.0000445 AC: 5AN: 112304Hom.: 0 Cov.: 24 AF XY: 0.0000580 AC XY: 2AN XY: 34512
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.14T>A (p.F5Y) alteration is located in exon 3 (coding exon 1) of the TCEAL2 gene. This alteration results from a T to A substitution at nucleotide position 14, causing the phenylalanine (F) at amino acid position 5 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at